Lillian L. SiuMD, FRCPC
Lillian L. Siu, MD, FRCPC, is a senior medical oncologist at Princess Margaret Cancer Centre and a Professor of Medicine at the University of Toronto. She directs the Phase I Program and the Cancer Genomics Program and is the clinical leader for the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre. Dr. Siu is also the Principal Investigator of the Princess Margaret Phase I Consortium as part of the U.S. National Cancer Institute Experimental Therapeutics Clinical Trials Network. In addition to serving on the ASCO Board of Directors, Dr. Siu also serves on the Cancer Education Committee.
Dr. Siu has been actively involved in the American Association for Cancer Research, she currently is a member of the Nominating Committee and has served previously as Chair of the Annual Meeting Educational Program Committee and member of the Scientific Program Committee. She was the recipient of the U.S. National Cancer Institute Michaele C. Christian Award in Oncology Drug Development in 2010 and served as the co-chair of Investigational Drug Steering Committee in 2013-2014.
Dr. Siu obtained her medical degree at the University of Toronto, completed her fellowship at Princess Margaret Cancer Centre, and completed drug development fellowships at Princess Margaret Cancer Centre and the University of Texas Science Center San Antoni